Budesonide Capsule, Coated Pellets
Product Images NDC 68382-720

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Budesonide (NDC 68382-720). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2f46f4cf 9f5a 43f4 871c 572414ad619b 01

FDA Label Image

2f46f4cf 9f5a 43f4 871c 572414ad619b 02

2f46f4cf 9f5a 43f4 871c 572414ad619b 02
This is a medicine description for Budesonide delayed-release capsules. The capsules contain 3mg of Budesonide and usual dosage is 3 capsules per day. The capsules should be stored at a controlled room temperature and dispensed in a light container, away from children's reach. The medicine is distributed by Zydus Pharmaceuticals (USA).*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.